MarketScreener Homepage > Equities > NASDAQ OMX COPENHAGEN > Novo Nordisk A/S NOVO B DK0060534915

Report

Real-time Estimate CHI-X - 10/23 05:17:54 am
447.125	DKK		+0.68%

10/16

NOVO NORDISK : Buy rating from Goldman Sachs

10/14

NOVO NORDISK : Buy rating from JP Morgan

10/12

NOVO NORDISK : Credit Suisse gives a Buy rating

News

Official Publications

Sector news

MarketScreener Strategies

Analyst Recommendations

Sector news Pharmaceuticals - NEC

10/22	ROCHE HOLDINGS AG : Goldman Sachs maintains a Buy rating	MD
10/22	GRAIN HIGHLIGHTS : Top Stories of the Day	DJ
10/22	LIVESTOCK HIGHLIGHTS : Top Stories of the Day	DJ
10/22	Materials Up On Stimulus Bets, Copper Gains -- Materials Roundup	DJ
10/22	BAYER : Request for Roundup Appeal Rejected by California Court	DJ
10/22	Pfizer, J&J urge clarity from FDA on future of COVID-19 vaccine trials once a..	RE
10/22	European cities plead for more flu shots as winter looms, pandemic rages	RE
10/22	PFIZER : How Pfizer Partner BioNTech Became a Leader in Coronavirus Vaccine Race	DJ
10/22	Covid-19 Vaccine Makers to Face Challenges When Recognizing Revenue	DJ
10/22	Dr Reddy's isolates data center services after cyberattack	RE
10/22	Trial begins in Samsung leader Jay Y. Lee's suspected fraud, stock manipulati..	RE
10/22	DR REDDY LABORATORIES : Data breach prompts India's Dr Reddy's to shut key plant..	RE
10/22	ROCHE : Atea team up on potential COVID-19 pill	RE
10/22	Britain partners with Oxford firm to assess coronavirus vaccine T cell respon..	RE
10/21	Fujifilm partners Shanghai firm to seek China COVID-19 approval for Avigan	RE
10/21	S.Korea sticks to flu vaccine plan despite safety fears after 25 die	RE
10/21	Wall Street banks see rare payday bonanza in India despite pandemic	RE
10/21	Number of South Koreans dying after flu shot rises, prompts vaccine worries	RE
10/21	ASTRAZENECA : Volunteer in AstraZeneca/Oxford Coronavirus Vaccine Trial Dies in ..	DJ
10/21	ROCHE : COVID SCIENCE-COVID-19 complication rates far higher than for flu; open ..	RE
10/21	ASTRAZENECA : Operation Warp Speed Chief Slaoui Expects U.S. Trials Of Vaccines ..	RE
10/21	Ecuador signs COVID-19 vaccine supply deals with pharma companies	RE
10/21	ASTRAZENECA : Volunteer in AstraZeneca/Oxford Coronavirus Vaccine Trial Dies in ..	DJ
10/21	GLAXOSMITHKLINE : JP Morgan gives a Neutral rating	MD
10/21	ASTRAZENECA : Deceased Astrazeneca Trial Volunteer Didn't Receive The Vaccine So..	RE
10/21	PROTHENA : Shares Rise 7% on Prasinezumab Study With Roche	DJ
10/21	AstraZeneca COVID-19 vaccine trial Brazil volunteer dies, trial to continue	RE
10/21	BAYER : Monsanto loses final appeal over French farmer's weedkiller accident	RE
10/21	BIOGEN : readies for U.S. launch of Alzheimer's drug ahead of FDA meeting	RE
10/21	PTC Therapeutics Says Evrysdi Approved in Brazil, Japan NDA Filed	DJ
10/21	Lilly hires external adviser for COVID-19 drug plant problems	RE
10/21	REGENERON PHARMACEUTICALS : Lilly hires external adviser for COVID-19 drug plant..	RE
10/21	Brazil's Bolsonaro rejects plan to buy China's Sinovac vaccine; health minist..	RE
10/21	BAYER AG : JP Morgan gives a Neutral rating	MD
10/21	BIOGEN : Cuts Guidance Amid Competition From Generics	DJ
10/21	BIOGEN : Posts Lower 4Q Profit as Pharmaceutical Revenue Declines	DJ
10/21	BIOGEN : readies for U.S. launch of Alzheimer's drug ahead of FDA meeting	RE
10/21	Covid-19 Vaccines to Be Stored Secretly Under Tight Security	DJ
10/21	SANOFI : EU signs supply deal with J&J on potential COVID-19 vaccine	RE
10/21	MERCK KGAA : Morgan Stanley reaffirms its Neutral rating	MD
10/21	NOVARTIS AG : Morgan Stanley keeps its Buy rating	MD
10/21	Pfizer Sets Up Its 'Biggest Ever' Vaccination Distribution Campaign	DJ
10/21	ORION OYJ : Finnish drugmaker Orion's third-quarter profit and sales fall	RE
10/21	BAYER AG : Morgan Stanley reiterates its Buy rating	MD
10/21	MERCK KGAA : Bernstein reiterates its Neutral rating	MD
10/21	WUXI BIOLOGICS CAYMAN : Shares Soar on Upbeat Revenue Guidance, China's Vaccine ..	DJ
10/21	GSK to launch late-stage testing of syncytial virus vaccine	RE
10/20	EXCLUSIVE : U.S. trial of AstraZeneca COVID-19 vaccine may resume this week - so..	RE
10/20	EXCLUSIVE : U.S. trial of AstraZeneca COVID-19 vaccine may resume this week - so..	RE
10/20	Mexico could share some COVID-19 vaccine liabilities with laboratories	RE

1 2 3 4 5 6 7 8 9 10 Next

Analysis

New $1 billion fund aims to steer antibiotic companies in tough market

MarketScreener Homepage > Equities > NASDAQ OMX COPENHAGEN > Novo Nordisk A/S NOVO B DK0060534915

NOVO NORDISK A/S